Medical/Pharmaceuticals

International Health Innovation & Exchange Association (IHIEA) Launches in Hong Kong and Unveils Six-Point Action Blueprint

Focusing on cross-border healthcare, continuing medical education, innovation translation, Global Medical Excellence Center certification, data collaboration and standards for emerging technologies HONG KONG, June 29, 2026 /PRNewswire/ -- The International Health Innovation & Exchange Assoc...

2026-06-29 11:38 1215

4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia

Non-contrast, ventilation-perfusion imaging—from routine chest CT scans MELBOURNE, Australia, June 29, 2026 /PRNewswire/ -- 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has Therapeutic Goods Administration (TGA) approval a...

2026-06-29 11:04 1735

Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 28, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...

2026-06-29 09:27 1989

Sisram Medical's China Manufacturing Facility Commences Operations as First Locally Produced Alma Rejuve Rolls Off the Line

Localization strategy advances with strengthened end-to-end capabilities across R&D, manufacturing and commercialization HONG KONG, June 28, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices (EBD), injectables, and...

2026-06-29 09:00 2882

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recog...

2026-06-27 06:01 3518

Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership

SILICON VALLEY, Calif., June 27, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world...

2026-06-27 02:30 3591

Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted

NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by Jiangsu Vcare PharmaTech Co.,Ltd. (Vcare PharmaTech), has been officially accepted by the NMPA. The drug has now entered the NDA...

2026-06-26 22:30 3945

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

* Recommendation follows an Article 20 non-pharmacovigilance procedure  * Patients currently on TAVNEOS treatment should consult their treating physician   ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the...

2026-06-26 21:06 4615

Beyond Injections: S-CELL Unveils Breakthrough "Endogenous GLP-1" Formula Powered by Akkermansia P9 Signaling and CoreBiome® Technology

HONG KONG, June 26, 2026 /PRNewswire/ -- S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering formula represents a paradigm shift in weight manageme...

2026-06-26 14:42 3517

Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia

SHANGHAI, June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that China's National Medical Products...

2026-06-26 10:08 4640

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

EPLive 2026 included 1,600 of the world's top cardiac electrophysiology experts AUSTIN, Texas, June 26, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its eighth international symposium on complex arrhythmias on May 28-29, 2026. This year's...

2026-06-26 02:55 3536

Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer

Racura Oncology has dosed the first patient in the HARNESS-1 Phase 1a/b trial of RC220 in combination with osimertinib for EGFR-mutant non-small cell lung cancer. The study will assess safety, pharmacokinetics, ctDNA dynamics and early clinical activity of RC220 as a strategy to address therapeut...

2026-06-25 22:51 3482

FIT KING Highlights How Different Consumer Routines Are Shaping At-Home Recovery Needs

The wellness brand outlines how its at-home recovery lineup matches active lifestyles, busy workdays, travel routines, first-time users, and everyday home wellness needs NEW YORK, June 25, 2026 /PRNewswire/ -- As recovery continues to move beyond elite athletics and into everyday wellness, FIT K...

2026-06-25 21:00 3363

CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand

* Arrotex, the pharmaceutical commercialization platform of DBG, Australia's leading diversified healthcare group, will be responsible for the registration, market access, and commercialization of sugemalimab in Australia and New Zealand. * This partnership marks sugemalimab's fifth internati...

2026-06-25 17:44 4003

Haier Biomedical Debuts Innovative Automated Low-Carbon Cold Storage Products at Two Major Global Industry Trade Fairs

From Europe Biobank Week 2026 in Prague to Interphex Week Tokyo 2026, Haier Biomedical continuously strengthens global life sciences market presence through localized innovative products and profound ecosystem partnerships QINGDAO, China, June 25, 2026 /PRNewswire/ -- Haier Biomedical

2026-06-25 17:34 4489

Malaysian Patient Underwent Advanced Heart Procedure at SinoUnited Health

SHANGHAI, June 25, 2026 /PRNewswire/ -- A Malaysian patient has successfully undergone pulse field ablation (PFA) for persistent atrial fibrillation (AF) in Shanghai. The procedure, performed by internationally renowned cardiac electrophysiologist Dr. Feifan Ouyang, has successfully restored the ...

2026-06-25 14:15 4468

C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework

CHENGDU, China, June 25, 2026 /PRNewswire/ -- On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel of experts from the Sichuan Provincial Center for Drug Evaluation and the National Defense Science and Industry Adminis...

2026-06-25 11:33 3483

Dimora Medical has joined the NPIAP Corporate Advisory Council as an Honorary Member

NEW YORK, June 24, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has officially joined the National Pressure Injury Advisory Panel (NPIAP) as a corporate member, marking a new step in its engagement with the global clinical community focused on pre...

2026-06-25 11:24 3776

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific

Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies SHANGHAI, June 25, 2026 /PRNewswire/ -- ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and development, and Samsung Bioepis C...

2026-06-25 07:30 4600

Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region

ABU DHABI, UAE, June 25, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has announced a  collaboration with global pharmaceutical leader MSD (Merck & Co., Inc., Rahway, New...

2026-06-25 03:15 4047
1 ... 6789101112 ... 648